Low-dose transdermal hormone therapy does not interfere with the blood pressure of hypertensive menopausal women: A pilot study

Blood Pressure Monitoring

Volumn 13, Issue 5, 2008, Pages 277-283

  De Carvalho, Márcia N ^a,b   Nobre, Fernando ^b   Mendes, Maria C ^a   Dos Reis, Rosana M ^a   Ferriani, Rui A ^a   De Sá, F Silva ^a  

^a Department of Gynecology and Obstetrics ^*  (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Ambulatory blood pressure monitoring; Hormone therapy; Hypertension; Lipids; Postmenopause

Indexed keywords

ENALAPRIL MALEATE; ESTRADIOL PLUS NORETHISTERONE ACETATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCHLOROTHIAZIDE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTIHYPERTENSIVE THERAPY; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE MONITORING; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; LOW DRUG DOSE; MEAN ARTERIAL PRESSURE; MENOPAUSAL SYNDROME; PILOT STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; SIDE EFFECT; SLEEP WAKING CYCLE; SYSTOLIC BLOOD PRESSURE; TRANSDERMAL PATCH; TREATMENT DURATION; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; CASE-CONTROL STUDIES; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; HYPERTENSION; MENOPAUSE; MIDDLE AGED; NORETHINDRONE; PILOT PROJECTS;

EID: 53549128094     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBP.0b013e32830d4b60     Document Type: Article

References (34)

1. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Writing group for the women's health initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. J Am Med Assoc 2002; 288:321-333.
2. Affinito P, Palomba S, Bonifácio M, Fontana D, Izzo R, Trimarco B, et al. Effects of hormonal replacement therapy in postmenopausal hypertensive patients. Maturitas 2001; 40:75-83.
3. Kawecka-Jaszcz K, Czarnecka D, Olszanecka A, Rajzer M, Jankowski P. The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension. J Hum Hypertens 2002; 16:509-516.
4. Sumino H, Ichikawa S, Kumakura H, Takayama Y, Kanda T, Sakamaki T, et al. Effects of hormone replacement therapy on office and ambulatory blood pressure Japanese hypertensive postmenopausal women. Hypertens Res 2003; 26:369-376.
5. Czarnecka D, Kawecka-Jaszcz K, Olszanecka A, Dembinska-Kiec A, Malczewska-Malec M, Zdzienicka A, et al. The effect of hormone replacement therapy on endothelial function in postmenopausal women with hypertension. Med Sci Monit 2004; 10:CR55-CR61.
6. Kaya C, Dincer Cengiz S, Cengiz B, Akgun G. The long-term effects of low-dose 17beta-estradiol and dydrogesterone hormone replacement therapy on 24-h ambulatory blood pressure in hypertensive postmenopausal women: a 1 year randomized, prospective study. Climacteric 2006; 9:437-445.
7. Pickering TG, Harshfield GA, Devereux RB, Laragh JH. What is the role of ambulatory monitoring in the management of hypertensive patients? Hypertension 1985; 7:171-177.
8. Verdechia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, et al. Orcadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81:528-536.
9. Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campese VM. Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens 1994; 7:23-24.
10. Shimada K, Kawamoto A, Matsubayashi K, Nishimaga M, Kimura S, Ozawa T. Diurnal blood pressure variations and silent cerebrovascular damage in elderly hypertensive patients. J Hypertens 1992; 10:875-878.
11. Kikuya M, Hansen TW, Thijs L, Björklund-Bodegard K, Kuznetsova T, Ohkubo T, et al. International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes Investigators. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation 2007; 115:2145-2152.
12. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study. Am J Hypertens 2006; 19:243-250.
13. Nobre F, Mion D Jr. Is the area under blood pressure curve the best parameter to evaluate 24-hour ambulatory blood pressure monitoring data? Blood Press Monit 2005; 10:263-270.
14. White WB, Lund-Johansen P, Omvik P. Twenty-four hour blood pressure load as a surrogate end-point in assessing antihypertensive therapy. J Hypertens 1993; 11:S75-S80.
15. Zachariah PK, Sumner WE II . The clinical utility of blood pressure load in hypertension. Am J Hypertens 1993; 6:194S-197S.
16. Mion D Jr, Kohlmann O Jr, Machado CA, Amodeo C, Gomes M, Praxedes JN, et al. V Diretrizes Brasileiras de Hipertensāo Arterial. Rev Bras Hipertens 2006; 13:256-312.
17. Kupperman HS, Wetchler BB, Blatt MH. Contemporary therapy of the menopausal syndrome. JAMA 1959; 171:1627-1637.
18. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic significance of the nocturnal decline in blood pressure in individual with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002; 20:2183-2189.
19. Lobo RA, Bush T, Carr BR, Pickar JH. Effects of lower doses of conjugated equine estrogens and medroxypogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism. Fertil Steril 2001; 76:13-24.
20. The North American Menopause Society. Recommendations for estrogen and progestogen use in peri- and postmenopausal women: October 2004 position statement of The North American Menopause Society. Menopause 2004; 11:589-600.
21. Kannel WB. Hypertension and the risk of cardiovascular disease. In: Laragh JH, Brenner BM, editors. Hypertension. New York: Raven Press; 1990. pp. 101-117.
22. Rosenthal T, Oparil S. Hypertension in women. J Hum Hypertens 2000; 14:691-704.
23. Zanger D, Yang BK, Ardans J, Waclawiw MA, Csako G, Wahl LM, et al. Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management. J Am Coll Cardiol 2000; 36:1797-1802.
24. Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000; 133:933-941.
25. Jick H, Derby LE, Wald Meyers M, Vasilakis C, Newton KM. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. Lancet 1996; 348:981-983.
26. Gambacciani M, Ciaponi M, Cappagli B, Monteleone P, Benussi C, Bevilacqua G, et al. Effects of low-dose, continuous combined estradiol and noretisterone acetate on menopausal quality of life in early postmenopausal women. Maturitas 2003; 44:157-163.
27. Vongpatanasin W, Tuncel M, Mansour Y, Arbique D, Victor RG. Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women. Circulation 2001; 103:2903-2908.
28. Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 1994; 89:1501-1510.
29. Mercuro G, Zoncu S, Piano D, Pilia I, Lao A, Melis GB, et al. Estradiol-17β reduces blood pressure and restores the normal amplitude of the circadian blood pressure rhythm in postmenopausal hypertension. Am J Hypertens 1998; 11:909-913.
30. Butkevich A, Abraham C, Phillips RA. Hormone replacement therapy and 24-h blood pressure profile in postmenopausal women. Am J Hypertens 2000; 13:1039-1041.
31. Staessen J, Thijs L, Fagard R, O'Brien ET, Clement D, De Leeuw PW, et al. For the Systolic Hypertension in Europe Trial Investigators. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. J Am Med Assoc 1999; 282:539-546.
32. Ohkubo T, Hozawa A, Nagai K, Kikuya M, Tsuji I, Ito S, et al. Prediction of stroke by ambulatory blood pressure monitoring versus screening blood pressure measurements in a general population: the Ohasama Study. J Hypertens 2000; 18:847-854.
33. Viazzi F, Leoncini G, Ratto E, Vaccaro V, Tomolillo C, Falqui V, et al. Microalbuminuria, blood pressure load, and systemic vascular permeability in primary hypertension. Am J Hypertens 2006; 19:1183-1189.
34. Enstrom I, Lidfeldt J, Lindholm LH, Nerbrand C, Pennert K, Samsioe G. Does blood pressure differ between users and nonusers of hormone replacement therapy? The Women's Health in the Lund Area (WHILA) study. Blood Press 2002; 11:240-243.